Janus Henderson Group’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.5M Sell
186,163
-556
-0.3% -$36.2K 0.01% 751
2025
Q4
$15M Buy
186,719
+164,263
+731% +$11M 0.01% 666
2025
Q3
$1.09M Hold
22,456
﹤0.01% 1617
2025
Q2
$1.68M Hold
22,456
﹤0.01% 1371
2025
Q1
$1.42M Sell
22,456
-37,980
-63% -$2.58M ﹤0.01% 1448
2024
Q4
$4.72M Buy
60,436
+13,920
+30% +$1.12M ﹤0.01% 930
2024
Q3
$3.74M Buy
46,516
+7,417
+19% +$599K ﹤0.01% 1002
2024
Q2
$3.24M Buy
39,099
+9,369
+32% +$824K ﹤0.01% 1032
2024
Q1
$2.54M Buy
29,730
+6,287
+27% +$493K ﹤0.01% 1181
2023
Q4
$2.01M Buy
23,443
+688
+3% +$59.5K ﹤0.01% 1250
2023
Q3
$2.04M Buy
22,755
+4
+0% +$357 ﹤0.01% 1178
2023
Q2
$1.94M Sell
22,751
-29
-0.1% -$2.45K ﹤0.01% 1262
2023
Q1
$1.88M Buy
22,780
+12,287
+117% +$995K ﹤0.01% 1302
2022
Q4
$825K Buy
+10,493
New +$843K ﹤0.01% 1462
2022
Q3
Sell
-10,302
Closed -$671K 2336
2022
Q2
$671K Sell
10,302
-18
-0.2% -$1.06K ﹤0.01% 1576
2022
Q1
$652K Sell
10,320
-433,545
-98% -$23.6M ﹤0.01% 1736
2021
Q4
$23.5M Sell
443,865
-760,819
-63% -$46.4M 0.01% 748
2021
Q3
$85M Buy
1,204,684
+512,612
+74% +$32.3M 0.04% 394
2021
Q2
$46.1M Buy
+692,072
New +$49M 0.02% 584

Other funds holding HAE

Janus Henderson Group's HAE Position: Q1 2026 in Review

Janus Henderson Group reduced its Haemonetics (HAE) stake by 0.3% in Q1 2026, selling an estimated $36.2K and leaving 186,163 shares worth $10.5M. The position accounts for 0.01% of the portfolio, ranked #751.

Janus Henderson Group first reported a position in HAE in Q2 2021 and has held it in 19 quarters since. The position peaked at $85M in Q3 2021. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Janus Henderson Group held 186,163 shares of Haemonetics worth $10.5M as of Q1 2026.
  • Janus Henderson Group sold 556 Haemonetics shares in Q1 2026, an estimated $36.2K.
  • Haemonetics made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #751 holding.
  • Janus Henderson Group first reported a position in Haemonetics in Q2 2021 and has held it in 19 quarters since.
  • Janus Henderson Group's Haemonetics position peaked at $85M in Q3 2021.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.